Efficacy and safety of Rasagiline in levodopa-treated Korean Parkinson's disease patients with motor fluctuations: Randomized, placebo-controlled, double-blind study

被引：0
|
作者：
Yun, Ji Young
Jeon, Beom
Kim, Jae Woo
Lee, Chong
Kim, Jong-Min
Cho, Jin Whan
Sohn, Young
Lee, Jee-Young
机构：
来源：
MOVEMENT DISORDERS | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
55
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [1] Rasagiline as add on therapy in levodopa-treated patients with Parkinson's disease and motor fluctuations: A randomized placebo-controlled study
    Oztekin, N.
    Oztekin, F.
    Okkan, H.
    Ak, F.
    Bilen, S.
    MOVEMENT DISORDERS, 2009, 24 : S271 - S272
  • [2] A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations - The PRESTO study
    Schwid, SR
    Shoulson, I
    Stern, M
    Oakes, D
    Kieburtz, K
    Fahn, S
    Blinclauer, K
    DeMarcaida, A
    Elmer, L
    Davis, K
    Fazzini, E
    Chin, L
    Scott, B
    Wilcox, C
    Colcher, A
    Reichwein, S
    Hauser, R
    Gauger, L
    Leehey, M
    Lewitt, P
    Kaminski, P
    Harrison, M
    Rost-Ruffner, E
    Racette, B
    Frei, K
    Luong, N
    Pahwa, R
    Dicarlo, J
    Kawai, C
    Jennings, D
    Caplan, K
    Fink, JS
    Novak, P
    Thomas, CA
    Chouinard, S
    Beauvais, C
    Tabbal, S
    Patterson, J
    Fernandez, H
    Bertoni, JM
    Skrypnik, L
    Panisset, M
    Fortin, MJ
    Molho, E
    Nash, J
    Dalvi, A
    Schwiterman, D
    Goetz, C
    Janko, K
    Mendis, T
    ARCHIVES OF NEUROLOGY, 2005, 62 (02) : 241 - 248
  • [3] A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
    Ferreira, J. J.
    Rascol, O.
    Poewe, W.
    Sampaio, C.
    Rocha, F.
    Nunes, T.
    Almeida, L.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S195 - S195
  • [4] Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease
    Olanow, CW
    Kieburtz, K
    Stern, M
    Watts, R
    Langston, MW
    Guarnieri, M
    Hubble, J
    Atchison, P
    Bartel, D
    Bernik, C
    Bertoni, J
    Bharucha, K
    Blady, D
    Brandabur, M
    Chippendale, T
    Cleeremans, B
    Comella, C
    Counihan, T
    Durso, R
    Edelsohn, L
    Ellis, J
    Elmer, L
    Evans, B
    Forchetti, C
    Freeman, A
    Galvez-Jimenez, N
    Gazda, S
    Gollomp, S
    Gracies, J
    Greeley, D
    Harris, J
    Hauser, R
    Hershey, L
    Hoehn, M
    Hoffsteter, M
    Hormes, J
    Hubble, J
    Hutton, T
    Jankovic, J
    Kaminow, L
    Kassicieh, D
    Kirzinger, S
    Kishner, R
    Klapper, J
    Knox, C
    Koller, W
    Leonard, H
    Levin, K
    LeWitt, P
    Marcadis, A
    ARCHIVES OF NEUROLOGY, 2004, 61 (10) : 1563 - 1568
  • [5] Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with ''wearing-off'' phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial
    Myllyla, VV
    Jackson, M
    Larsen, JP
    Baas, H
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 (04) : 333 - 341
  • [6] Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhang, Zhenxin
    Wang, Jian
    Chen, Shengdi
    Liu, Chunfeng
    Zhang, Baorong
    Peng, Rong
    Sun, Shenggang
    Sun, Xiangru
    Zhao, Gang
    Qu, Qiumin
    Li, Yansheng
    Zhu, Suiqiang
    Pan, Xiaoping
    Shao, Ming
    Wang, Yanping
    TRANSLATIONAL NEURODEGENERATION, 2018, 7
  • [7] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
    Hattori, N.
    Takeda, A.
    Takeda, S.
    Nishimura, A.
    Kitagawa, T.
    Mochizuki, H.
    Nagai, M.
    Takahashi, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
  • [8] Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhenxin Zhang
    Jian Wang
    Shengdi Chen
    Chunfeng Liu
    Baorong Zhang
    Rong Peng
    Shenggang Sun
    Xiangru Sun
    Gang Zhao
    Qiumin Qu
    Yansheng Li
    Suiqiang Zhu
    Xiaoping Pan
    Ming Shao
    Yanping Wang
    Translational Neurodegeneration, 7
  • [9] Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
    Rascol, O.
    Bronzova, J.
    Hauser, R. A.
    Lang, A. E.
    Sampaio, C.
    Theeuwes, A.
    Van de Witte, S. V.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (04) : 370 - 376
  • [10] Safinamide as an adjunct to levodopa significantly improved motor fluctuations in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study
    Borgohain, R.
    Szasz, J.
    Bhatt, M.
    Rossetti, S.
    Lucini, V.
    Anand, R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S115 - S115
12345